Skip to main content
Top
Published in: Pediatric Cardiology 1/2008

01-01-2008

Prognostic Value of B-Type Natriuretic Peptide in Surgical Palliation of Children with Single-Ventricle Congenital Heart Disease

Authors: J. G. Berry, B. Askovich, R. E. Shaddy, J. A. Hawkins, C. G. Cowley

Published in: Pediatric Cardiology | Issue 1/2008

Login to get access

Abstract

The objective of this prospective study was to assess the prognostic role of perioperative B-type natriuretic peptide (BNP) levels in infants and children with single-ventricle congenital heart disease undergoing Norwood, bidirectional cavopulmonary anastomosis (BCPA), or Fontan operation. BNP levels were measured at baseline, after cardiopulmonary bypass, 6 to 12 hours after surgery, and then daily until indwelling vascular catheters were removed. Outcome measures included length of mechanical ventilation, inotropic support, and hospital stay. Twenty subjects underwent 23 surgical procedures (13 Norwood, 5 BCPA, and 5 Fontan). BNP levels were significantly higher in patients undergoing a Norwood procedure compared with a BCPA or Fontan procedure (p < 0.01). BNP levels measured 6 to 12 hours after surgery were predictive of duration of hospitalization (p = 0.005) and inotropic support (p = 0.01). An increase in BNP level within 48 hours of extubation was observed in 92% of patients undergoing a Norwood procedure. Early postoperative BNP levels correlate significantly with the ensuing duration of inotropic support and length of hospitalization. An increase in BNP after extubation may be reflective of the degree of underlying cardiopulmonary instability. Further investigation is necessary to define this important relation.
Literature
1.
go back to reference Ationu A, Singer DR, Smith A, Elliott M, Burch M, Carter ND (1993) Studies of cardiopulmonary bypass in children: Implications for the regulation of brain natriuretic peptide. Cardiovasc Res 27:1538–1541PubMedCrossRef Ationu A, Singer DR, Smith A, Elliott M, Burch M, Carter ND (1993) Studies of cardiopulmonary bypass in children: Implications for the regulation of brain natriuretic peptide. Cardiovasc Res 27:1538–1541PubMedCrossRef
2.
go back to reference Ationu A, Sorensen K, Whitehead B, Singer D, Burch M, Carter ND (1993) Ventricular expression of brain natriuretic peptide gene following orthotopic cardiac transplantation in children―A three year follow up. Cardiovasc Res 27:2135–2139PubMed Ationu A, Sorensen K, Whitehead B, Singer D, Burch M, Carter ND (1993) Ventricular expression of brain natriuretic peptide gene following orthotopic cardiac transplantation in children―A three year follow up. Cardiovasc Res 27:2135–2139PubMed
3.
go back to reference Chen HH, Burnett JC Jr. (1999) The natriuretic peptides in heart failure: Diagnostic and therapeutic potentials. Proc Assoc Am Phys 111:406–416PubMed Chen HH, Burnett JC Jr. (1999) The natriuretic peptides in heart failure: Diagnostic and therapeutic potentials. Proc Assoc Am Phys 111:406–416PubMed
4.
go back to reference Costello JM, Backer CL, Checchia PA, Mavroudis C, Seipelt RG, Goodman DM (2004) Alterations in the natriuretic hormone system related to cardiopulmonary bypass in infants with congestive heart failure. Pediatr Cardiol 25:347–353PubMedCrossRef Costello JM, Backer CL, Checchia PA, Mavroudis C, Seipelt RG, Goodman DM (2004) Alterations in the natriuretic hormone system related to cardiopulmonary bypass in infants with congestive heart failure. Pediatr Cardiol 25:347–353PubMedCrossRef
5.
go back to reference Costello JM, Backer CL, Checchia PA, Mavroudis C, Seipelt RG, Goodman DM (2005) Effect of cardiopulmonary bypass and surgical intervention on the natriuretic hormone system in children. J Thorac Cardiovasc Surg 130:822–829PubMedCrossRef Costello JM, Backer CL, Checchia PA, Mavroudis C, Seipelt RG, Goodman DM (2005) Effect of cardiopulmonary bypass and surgical intervention on the natriuretic hormone system in children. J Thorac Cardiovasc Surg 130:822–829PubMedCrossRef
6.
go back to reference Cowley CG, Bradley JD, Shaddy RE (2004) B-type natriuretic peptide levels in congenital heart disease. Pediatr Cardiol 25:336–340PubMedCrossRef Cowley CG, Bradley JD, Shaddy RE (2004) B-type natriuretic peptide levels in congenital heart disease. Pediatr Cardiol 25:336–340PubMedCrossRef
7.
go back to reference Cuthbertson BH, McKeown A, Croal BL, Mutch WJ, Hillis GS (2005) Utility of B-type natriuretic peptide in predicting the level of peri- and postoperative cardiovascular support required after coronary artery bypass grafting. Crit Care Med 33:437–442PubMedCrossRef Cuthbertson BH, McKeown A, Croal BL, Mutch WJ, Hillis GS (2005) Utility of B-type natriuretic peptide in predicting the level of peri- and postoperative cardiovascular support required after coronary artery bypass grafting. Crit Care Med 33:437–442PubMedCrossRef
8.
go back to reference Das SR, Drazner MH, Dries DL, Vega GL, Stanek HG, Abdullah SM, et al. (2005) Impact of body mass and body composition on circulating levels of natriuretic peptides: Results from the Dallas Heart Study. Circulation 112:2163–2168PubMedCrossRef Das SR, Drazner MH, Dries DL, Vega GL, Stanek HG, Abdullah SM, et al. (2005) Impact of body mass and body composition on circulating levels of natriuretic peptides: Results from the Dallas Heart Study. Circulation 112:2163–2168PubMedCrossRef
9.
go back to reference Doust JA, Pietrzak E, Dobson A, Glasziou P (2005) How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: Systematic review. Br Med J 330:625CrossRef Doust JA, Pietrzak E, Dobson A, Glasziou P (2005) How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: Systematic review. Br Med J 330:625CrossRef
10.
go back to reference Hutfless R, Kazanegra R, Madani M, Bhalla MA, Tulua-Tata A, Chen A, et al. (2004) Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 43:1873–1879PubMedCrossRef Hutfless R, Kazanegra R, Madani M, Bhalla MA, Tulua-Tata A, Chen A, et al. (2004) Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 43:1873–1879PubMedCrossRef
11.
go back to reference Kawamura T, Wago M, Kawaguchi H, Tahara M, Yuge M (2000) Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease. Pediatr Int 42:241–248PubMedCrossRef Kawamura T, Wago M, Kawaguchi H, Tahara M, Yuge M (2000) Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease. Pediatr Int 42:241–248PubMedCrossRef
12.
go back to reference Koch A, Singer H (2003) Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart 89:875–878PubMedCrossRef Koch A, Singer H (2003) Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart 89:875–878PubMedCrossRef
13.
go back to reference Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R (2005) N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 352:666–675PubMedCrossRef Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R (2005) N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 352:666–675PubMedCrossRef
14.
go back to reference Mair J, Friedl W, Thomas S, Puschendorf B (1999) Natriuretic peptides in assessment of left-ventricular dysfunction. Scand J Clin Lab Invest 230(Suppl):132–142CrossRef Mair J, Friedl W, Thomas S, Puschendorf B (1999) Natriuretic peptides in assessment of left-ventricular dysfunction. Scand J Clin Lab Invest 230(Suppl):132–142CrossRef
15.
go back to reference McCullough PA, Sandberg KR (2003) B-type natriuretic peptide and renal disease. Heart Fail Rev 8:355–358PubMedCrossRef McCullough PA, Sandberg KR (2003) B-type natriuretic peptide and renal disease. Heart Fail Rev 8:355–358PubMedCrossRef
16.
go back to reference Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, et al. (1993) Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 88:82–91PubMed Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, et al. (1993) Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 88:82–91PubMed
17.
go back to reference Qi W, Mathisen P, Kjekshus J, Simonsen S, Bjornerheim R, Endresen K, et al. (2001) Natriuretic peptides in patients with aortic stenosis. Am Heart J 142:725–732PubMedCrossRef Qi W, Mathisen P, Kjekshus J, Simonsen S, Bjornerheim R, Endresen K, et al. (2001) Natriuretic peptides in patients with aortic stenosis. Am Heart J 142:725–732PubMedCrossRef
18.
go back to reference Shih CY, Sapru A, Oishi P, Azakie A, Karl TR, Harmon C, et al. (2006) Alterations in plasma B-type natriuretic peptide levels after repair of congenital heart defects: A potential perioperative marker. J Thorac Cardiovasc Surg 131:632–638PubMedCrossRef Shih CY, Sapru A, Oishi P, Azakie A, Karl TR, Harmon C, et al. (2006) Alterations in plasma B-type natriuretic peptide levels after repair of congenital heart defects: A potential perioperative marker. J Thorac Cardiovasc Surg 131:632–638PubMedCrossRef
19.
go back to reference Stein BC, Levin RI (1998) Natriuretic peptides: Physiology, therapeutic potential, and risk stratification in ischemic heart disease. Am Heart J 135:914–923PubMedCrossRef Stein BC, Levin RI (1998) Natriuretic peptides: Physiology, therapeutic potential, and risk stratification in ischemic heart disease. Am Heart J 135:914–923PubMedCrossRef
20.
go back to reference Sun LS, Dominguez C, Mallavaram NA, Quaegebeur JM (2005) Dysfunction of atrial and B-type natriuretic peptides in congenital univentricular defects. J Thorac Cardiovasc Surg 129:1104–1110PubMedCrossRef Sun LS, Dominguez C, Mallavaram NA, Quaegebeur JM (2005) Dysfunction of atrial and B-type natriuretic peptides in congenital univentricular defects. J Thorac Cardiovasc Surg 129:1104–1110PubMedCrossRef
21.
go back to reference Takemura G, Fujiwara H, Takatsu Y, Fujiwara T, Nakao K (1995) Ventricular expression of atrial and brain natriuretic peptides in patients with myocarditis. Int J Cardiol 52:213–222PubMedCrossRef Takemura G, Fujiwara H, Takatsu Y, Fujiwara T, Nakao K (1995) Ventricular expression of atrial and brain natriuretic peptides in patients with myocarditis. Int J Cardiol 52:213–222PubMedCrossRef
22.
go back to reference Yamada Y, Goto J, Yokota M (1997) Brain natriuretic peptide is a sensitive indicator of impaired left-ventricular function in elderly patients with cardiovascular disease. Cardiology 88:401–407PubMedCrossRef Yamada Y, Goto J, Yokota M (1997) Brain natriuretic peptide is a sensitive indicator of impaired left-ventricular function in elderly patients with cardiovascular disease. Cardiology 88:401–407PubMedCrossRef
23.
go back to reference Yildiz R, Yildirim B, Karincaoglu M, Harputluoglu M, Hilmioglu F (2005) Brain natriuretic peptide and severity of disease in non-alcoholic cirrhotic patients. J Gastroenterol Hepatol 20:1115–1120PubMedCrossRef Yildiz R, Yildirim B, Karincaoglu M, Harputluoglu M, Hilmioglu F (2005) Brain natriuretic peptide and severity of disease in non-alcoholic cirrhotic patients. J Gastroenterol Hepatol 20:1115–1120PubMedCrossRef
24.
go back to reference Yoshimura N, Yamaguchi M, Oshima Y, Oka S, Ootaki Y, Hasegawa T, et al. (2000) Suppression of the secretion of atrial and brain natriuretic peptide after total cavopulmonary connection. J Thorac Cardiovasc Surg 120:764–769PubMedCrossRef Yoshimura N, Yamaguchi M, Oshima Y, Oka S, Ootaki Y, Hasegawa T, et al. (2000) Suppression of the secretion of atrial and brain natriuretic peptide after total cavopulmonary connection. J Thorac Cardiovasc Surg 120:764–769PubMedCrossRef
25.
go back to reference Zhou L, Giacherio D, Cooling L, Davenport RD (2005) Use of B-natriuretic peptide as a diagnostic marker in the differential diagnosis of transfusion-associated circulatory overload. Transfusion 45:1056–1063PubMedCrossRef Zhou L, Giacherio D, Cooling L, Davenport RD (2005) Use of B-natriuretic peptide as a diagnostic marker in the differential diagnosis of transfusion-associated circulatory overload. Transfusion 45:1056–1063PubMedCrossRef
Metadata
Title
Prognostic Value of B-Type Natriuretic Peptide in Surgical Palliation of Children with Single-Ventricle Congenital Heart Disease
Authors
J. G. Berry
B. Askovich
R. E. Shaddy
J. A. Hawkins
C. G. Cowley
Publication date
01-01-2008
Publisher
Springer-Verlag
Published in
Pediatric Cardiology / Issue 1/2008
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-007-9012-3

Other articles of this Issue 1/2008

Pediatric Cardiology 1/2008 Go to the issue